Loading
PB
Pharmala Biotech Holdings Inc. Stock: price and insider trades · Canada
Pharmala Biotech Holdings Inc.: what insiders have been doing
This page follows insider dealings at Pharmala Biotech Holdings Inc. as filed with SEDI. The last twelve months, up to 24 October 2026, brought 21 filings signed by 7 insiders.
Open-market activity splits into 3 purchases totalling €3,369 and 6 sales totalling €23k; 2 insiders sit on the buying side and 1 insider on the selling side. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a sale of €16k by Macdonald, Fraser, published on 14 July 2026. The buyers include 2 senior executives.
The last purchase on record was published on 21 May 2026, which is 159 days ago. The median gap between a trade and its publication by SEDI is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For context, the typical company on the same exchange (median of 2,734 companies) published 14 filings over the same period, against 21 filings here. Looking back to 2021, when coverage begins, insiders filed 8 purchases and 11 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
57
Thresholds
n/a
Buy Volume
€30,087
8 ops. · all time
Sell Volume
€160,916
11 ops. · all time
Who traded when
BuySaleFraser Macdonald6 sales
Farnoud Kazemzadeh2 buys
Lennie Ryer1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
CA$0.18
Last declaration on 29 July 2026
Declarations57 total
1,000,000 sharesRights Performance Share UnitsTSXSEDI:4756687
Rights Performance Share UnitsTSXSEDI:4756686
45,500 shares@ CA$0.1413.6% of flowCommon SharesTSXSEDI:4753453
16,000 shares@ CA$0.1354.6% of flowCommon SharesTSXSEDI:4752399
186,800 shares@ CA$0.13553.8% of flowCommon SharesTSXSEDI:4752397
300 shares@ CA$0.140.1% of flowCommon SharesTSXSEDI:4752394
1,600 shares@ CA$0.140.5% of flowCommon SharesTSXSEDI:4752393
21,738 shares@ CA$0.1356.2% of flowCommon SharesTSXSEDI:4752392
100,000 shares@ CA$0.1021.2% of flowCommon SharesTSXSEDI:4736755
100,000 sharesOptionsTSXSEDI:4736754
150,000 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:4736752
150,000 sharesOptionsTSXSEDI:4736751
175,000 shares@ CA$0.10100.0% of flowOptionsTSXSEDI:4734887
Common SharesTSXSEDI:4722077
36,000 shares@ CA$0.15100.0% of flowCommon SharesTSXSEDI:4722078
Canonical exit: 6 Aug 2026 (T+90)
100,000 shares@ CA$0.1042.6% of flowCommon SharesTSXSEDI:4719680
1,286 sharesCommon SharesTSXSEDI:4710519
Canonical exit: 27 Jul 2026 (T+90)
267 sharesCommon SharesTSXSEDI:4710520
Canonical exit: 27 Jul 2026 (T+90)
750,000 sharesCommon SharesTSXSEDI:4710524
500,000 sharesCommon SharesTSXSEDI:4710526
Common SharesTSXSEDI:4709920
500,000 sharesCommon SharesTSXSEDI:4504477
500,000 sharesCommon SharesTSXSEDI:4451873
37,500 sharesCommon SharesTSXSEDI:4415911
37,500 sharesCommon SharesTSXSEDI:4415908
25 of 57 declarations
About Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc. is a company focused on developing pharmaceutical products based on cannabis. It is listed on the Toronto Stock Exchange.
